ADRB2 and pulmonary arterial hypertension: Further, assuming that IH is a major pathophysiologic basis for SAS [6], the low prevalence of PAH (∼20%) in SAS [1], [4] may be explained by the inhibition of PAH and RVH progress due to the HPV-attenuating βAR mechanism.